Skip to main content


Figure 4 | Molecular Cancer

Figure 4

From: Combining phenotypic and proteomic approaches to identify membrane targets in a ‘triple negative’ breast cancer cell type

Figure 4

Anti-CD73 antibody significantly inhibits the growth of pre-established MDA-MB-231 breast cancer xenograft tumours implanted into nude mice. MDA-MB-231 cells were implanted into mice at 3x106 cells/mouse and tumours were allowed to progress to 70 mm3. The anti-CD73 antibody or an isotype control antibody were dosed intraperitoneally on days 1, 5, 8, 12, 15, 19 and 22 (indicated by arrows). Each study group contained 10 mice.

Back to article page